Utilisation analysis of heart failure medicines listed on the Pharmaceutical Benefits Scheme (PBS)
Page last updated: 20 December 2024
At its September 2024 meeting, the Pharmaceutical Benefits Advisory Committee (PBAC) considered a report presenting a utilisation analysis of PBS-listed medicines for heart failure. The PBAC also considered advice from the Drug Utilisation Sub-Committee on the report, as well as sponsor comments.
The Utilisation analysis of PBS-listed medicines for heart failure report has now been published on the PBS website. If you have any questions relating to the report, please email PBSpostmarket@health.gov.au.
